Carregant...
With great power comes great vulnerability
The clinical responses to targeted drugs are often transient and do not always translate into meaningful overall survival due to the development of resistance. We discuss here that the greater power of drug resistant cells can be associated with significant newly-acquired vulnerabilities that can be...
Guardat en:
| Publicat a: | Mol Cell Oncol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6276853/ https://ncbi.nlm.nih.gov/pubmed/30525088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2018.1509488 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|